Neurocrine Bio. (NBIX) PT Lowered to $114 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 145.47 -0.63 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.10 | 52 Week High | $58.46 | |||
| Open | $145.70 | 52 Week Low | $31.25 | |||
| Day High | $147.48 | P/E | N/A | |||
| Day Low | $143.75 | EPS | $-0.69 | |||
| Volume | 604,526 | |||||
